NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers
In Brief: Cancer Control Needs More Oncologists, DCT recruiting for Prestigious Combines Job
Proposed Criteria For Establishing Carcinogenicity Listed
DFA Proposes Controversial Guidelines For Clinical Tests
Abstracts Of Papers From Therapeutic Radiology Meeting
NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
